BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36865094)

  • 1. Plasma extracellular vesicle transcriptome as a dynamic liquid biopsy in acute heart failure.
    Gokulnath P; Spanos M; Lehmann HI; Sheng Q; Rodosthenous R; Chaffin M; Varrias D; Chatterjee E; Hutchins E; Li G; Daaboul G; Rana F; Wang AM; Van Keuren-Jensen K; Ellinor PT; Shah R; Das S
    medRxiv; 2023 Feb; ():. PubMed ID: 36865094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles in heart failure - A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting.
    Matan D; Mobarrez F; Löfström U; Corbascio M; Ekström M; Hage C; Lyngå P; Persson B; Eriksson M; Linde C; Persson H; Wallén H
    Front Cardiovasc Med; 2022; 9():952974. PubMed ID: 36330003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.
    Hahn VS; Knutsdottir H; Luo X; Bedi K; Margulies KB; Haldar SM; Stolina M; Yin J; Khakoo AY; Vaishnav J; Bader JS; Kass DA; Sharma K
    Circulation; 2021 Jan; 143(2):120-134. PubMed ID: 33118835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF- DRY-OFF study.
    Cogliati C; Ceriani E; Gambassi G; De Matteis G; Perlini S; Perrone T; Muiesan ML; Salvetti M; Leidi F; Ferrara F; Sabbà C; Suppressa P; Fracanzani A; Montano N; Fiorelli E; Tripepi G; Gori M; Pitino A; Pietrangelo A
    Eur J Intern Med; 2022 Mar; 97():69-77. PubMed ID: 34844795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis and Co-Expression Network of mRNAs and lncRNAs in Pressure Overload-Induced Heart Failure.
    Chen S; Ma Q; Xue Y; Zhang J; Yang G; Wang T; Ma A; Bai L
    Front Genet; 2019; 10():1271. PubMed ID: 31921308
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Candidate Circulating RNA Markers for Coronary Artery Disease by Deep RNA-Sequencing in Human Plasma.
    Ward Z; Schmeier S; Pearson J; Cameron VA; Frampton CM; Troughton RW; Doughty RN; Richards AM; Pilbrow AP
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.
    Eidizadeh A; Schnelle M; Leha A; Edelmann F; Nolte K; Werhahn SM; Binder L; Wachter R
    ESC Heart Fail; 2023 Feb; 10(1):200-210. PubMed ID: 36184749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
    D'Assante R; Arcopinto M; Rengo G; Salzano A; Walser M; Gambino G; Monti MG; Bencivenga L; Marra AM; Åberg DN; De Vincentiis C; Ballotta A; Bossone E; Isgaard J; Cittadini A
    ESC Heart Fail; 2021 Apr; 8(2):1681-1686. PubMed ID: 33512777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EV-origin: Enumerating the tissue-cellular origin of circulating extracellular vesicles using exLR profile.
    Li Y; He X; Li Q; Lai H; Zhang H; Hu Z; Li Y; Huang S
    Comput Struct Biotechnol J; 2020; 18():2851-2859. PubMed ID: 33133426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating RNAs in prostate cancer patients.
    Mugoni V; Ciani Y; Nardella C; Demichelis F
    Cancer Lett; 2022 Jan; 524():57-69. PubMed ID: 34656688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure.
    Li D; Chen G; Yang J; Fan X; Gong Y; Xu G; Cui Q; Geng B
    PLoS One; 2013; 8(10):e77938. PubMed ID: 24205036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels.
    O'Grady T; Njock MS; Lion M; Bruyr J; Mariavelle E; Galvan B; Boeckx A; Struman I; Dequiedt F
    BMC Biol; 2022 Mar; 20(1):72. PubMed ID: 35331218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
    Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM
    Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell-derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy-In a model of human-induced pluripotent stem cell-derived cardiomyocytes.
    Constantin A; Comarița IK; Alexandru N; Filippi A; Bojin F; Gherghiceanu M; Vîlcu A; Nemecz M; Niculescu LS; Păunescu V; Georgescu A
    Front Pharmacol; 2022; 13():1003684. PubMed ID: 36299891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
    Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN
    Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Stimulation of α- and β-Adrenoceptors in Mice Differentially Alters Small RNA Content of Circulating Extracellular Vesicles.
    Kwon JS; Barr EW; Chuprun JK; Koch WJ
    Cells; 2021 May; 10(5):. PubMed ID: 34063503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.